Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Endometrial cancer · postmenopausal women with or without vasomotor symptoms

It is very uncertain whether tibolone changes endometrial cancer (all doses) compared with combined HT (very low certainty).

1 finding from 1 review

Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes only
OR 1.47 [0.23, 9.33]
5 studies · 3689 participants
Very low

Endometrial cancer · postmenopausal women with or without vasomotor symptoms

It is very uncertain whether tibolone changes endometrial cancer (all doses) compared with placebo (very low certainty).

1 finding from 1 review

Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes only
OR 2.04 [0.79, 5.24]
9 studies · 8504 participants
Very low